AIM: There is controversy and sparse data on whether substrate based techniques in addition to pulmonary vein isolation (PVI) confer benefit in the catheter ablation of persistent atrial fibrillation (AF), especially if long standing. We performed an observational study to assess whether substrate based ablation improved freedom from atrial arrhythmia. METHODS: A total of 286 patients undergoing first ablation procedures for persistent AF with PVI only(n = 79), PVI plus linear ablation(n = 85), or PVI plus complex fractionated electrogram (CFAE) and linear ablation(n = 107) were followed. Primary end point was freedom from atrial arrhythmia at one year. RESULTS: Mean duration of pre-procedure time in AF was 28+/-27 months.There were no differences in baseline characteristics between groups except a higher proportion of patients with a severely dilated LA in those receiving PVI+CFAEs+lines. Freedom from atrial arrhythmia was higher with a PVI+CFAE+lines strategy then for PVI alone (HR 1.56, 95% CI: 1.04-2.34, p=0.032) but was not higher with PVI+lines. Benefit of substrate modification was conferred for preprocedure times in AF of over 30 months. The occurrence of atrial tachycardia was higher when lines were added to the ablation strategy (HR 0.08, 95% CI: 0.01-0.59, p=0.014). Freedom from atrial arrhythmia at 1 year was higher with lower patient age, use of general anaesthetic (GA), normal or mildly dilated left atrium and decreasing time in AF. CONCLUSIONS: In patients with long standing persistent AF of over 30 months duration,CFAE ablation resulted in improved freedom from atrial arrhythmia. Increased freedom from atrial arrhythmia occurs in patients who are younger and have smaller atria, and with GA procedures. Linear ablation did not improve outcome and resulted in a higher incidence of atrial tachycardia.
AIM: There is controversy and sparse data on whether substrate based techniques in addition to pulmonary vein isolation (PVI) confer benefit in the catheter ablation of persistent atrial fibrillation (AF), especially if long standing. We performed an observational study to assess whether substrate based ablation improved freedom from atrial arrhythmia. METHODS: A total of 286 patients undergoing first ablation procedures for persistent AF with PVI only(n = 79), PVI plus linear ablation(n = 85), or PVI plus complex fractionated electrogram (CFAE) and linear ablation(n = 107) were followed. Primary end point was freedom from atrial arrhythmia at one year. RESULTS: Mean duration of pre-procedure time in AF was 28+/-27 months.There were no differences in baseline characteristics between groups except a higher proportion of patients with a severely dilated LA in those receiving PVI+CFAEs+lines. Freedom from atrial arrhythmia was higher with a PVI+CFAE+lines strategy then for PVI alone (HR 1.56, 95% CI: 1.04-2.34, p=0.032) but was not higher with PVI+lines. Benefit of substrate modification was conferred for preprocedure times in AF of over 30 months. The occurrence of atrial tachycardia was higher when lines were added to the ablation strategy (HR 0.08, 95% CI: 0.01-0.59, p=0.014). Freedom from atrial arrhythmia at 1 year was higher with lower patient age, use of general anaesthetic (GA), normal or mildly dilated left atrium and decreasing time in AF. CONCLUSIONS: In patients with long standing persistent AF of over 30 months duration,CFAE ablation resulted in improved freedom from atrial arrhythmia. Increased freedom from atrial arrhythmia occurs in patients who are younger and have smaller atria, and with GA procedures. Linear ablation did not improve outcome and resulted in a higher incidence of atrial tachycardia.
Authors: T Jared Bunch; J Peter Weiss; Brian G Crandall; Heidi T May; Tami L Bair; Jeffrey S Osborn; Jeffrey L Anderson; Donald L Lappe; J Brent Muhlestein; Jennifer Nelson; John D Day Journal: Pacing Clin Electrophysiol Date: 2009-11-02 Impact factor: 1.976
Authors: Luigi Di Biase; Sergio Conti; Prasant Mohanty; Rong Bai; Javier Sanchez; David Walton; Annie John; Pasquale Santangeli; Claude S Elayi; Salwa Beheiry; G Joseph Gallinghouse; Sanghamitra Mohanty; Rodney Horton; Shane Bailey; J David Burkhardt; Andrea Natale Journal: Heart Rhythm Date: 2010-11-02 Impact factor: 6.343
Authors: Jean-François Roux; Erica Zado; David J Callans; Fermin Garcia; David Lin; Francis E Marchlinski; Rupa Bala; Sanjay Dixit; Michael Riley; Andrea M Russo; Mathew D Hutchinson; Joshua Cooper; Ralph Verdino; Vickas Patel; Parijat S Joy; Edward P Gerstenfeld Journal: Circulation Date: 2009-09-08 Impact factor: 29.690
Authors: Julia Vogler; Stephan Willems; Arian Sultan; Doreen Schreiber; Jakob Lüker; Helge Servatius; Benjamin Schäffer; Julia Moser; Boris A Hoffmann; Daniel Steven Journal: J Am Coll Cardiol Date: 2015-12-22 Impact factor: 24.094
Authors: Hakan Oral; Aman Chugh; Kentaro Yoshida; Jean F Sarrazin; Michael Kuhne; Thomas Crawford; Nagib Chalfoun; Darryl Wells; Warangkna Boonyapisit; Srikar Veerareddy; Sreedhar Billakanty; Wai S Wong; Eric Good; Krit Jongnarangsin; Frank Pelosi; Frank Bogun; Fred Morady Journal: J Am Coll Cardiol Date: 2009-03-03 Impact factor: 24.094